Sriram Ryali
CIK 1762893 · Chief Financial Officer · last filed 2026-02-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$378.8K
Companies
3
Total Filings
15
Lifetime Open-Market Net
$45.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRBU | Chief Financial Officer | 72,360 | $1.64 | $118.7K | $24.7K | 3 | 2026-02-20 |
| CDXS | Chief Financial Officer | 175,791 | $1.48 | $260.2K | $19.9K | 3 | 2024-01-02 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Chief Financial Officer | 1,386 | $1.73 | $2.4K | $1.2K | 9 | 2022-03-14 |
Recent Filings · Page 2 of 2
15 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-15 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +16,250 | $0 | EDGAR |
| 2020-03-13 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +229 | $1.7K | EDGAR |
| 2019-09-06 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | +149 | $1.4K | EDGAR |
| 2019-04-22 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Buy (P) | +1,250 | $13.9K | EDGAR |
| 2019-01-04 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–15 of 15
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.